Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Li-Xu Yan

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

PLoS ONE

Multidisciplinary

2014

English

Related publications

Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study

Hematological Oncology

English

EBV-positive Diffuse Large B Cell Lymphoma, Not Otherwise Specified in a Man With Crohn’s Disease

English

P53 Expression Correlates With Poorer Survival and Augments the Negative Prognostic Effect of MYC Rearrangement, Expression or Concurrent MYC/BCL2 Expression in Diffuse Large B-Cell Lymphoma

English

C-Myc and BCL2: Correlation Between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma

Asian Pacific Journal of Cancer Prevention

2019

English

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Hematological Oncology

English

Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop

Hematological Oncology

English

Proteomic Profiling Identifies Outcome-Predictive Markers in Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

Blood advances

Hematology

2018

English

EBV-positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: 2018 Update on Diagnosis, Risk-Stratification and Management

American Journal of Hematology

Hematology

2018

English

The Significance of Pd-L1 and Pd1 Receptors Expression in Patients With Diffuse B-Cell Large-Cell Lymphoma

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Li-Xu Yan

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Related publications

Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study

EBV-positive Diffuse Large B Cell Lymphoma, Not Otherwise Specified in a Man With Crohn’s Disease

P53 Expression Correlates With Poorer Survival and Augments the Negative Prognostic Effect of MYC Rearrangement, Expression or Concurrent MYC/BCL2 Expression in Diffuse Large B-Cell Lymphoma

C-Myc and BCL2: Correlation Between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop

Proteomic Profiling Identifies Outcome-Predictive Markers in Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified

EBV-positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: 2018 Update on Diagnosis, Risk-Stratification and Management

The Significance of Pd-L1 and Pd1 Receptors Expression in Patients With Diffuse B-Cell Large-Cell Lymphoma